Aristolochic acid I suppressed iNOS gene expression and NF-κB activation in stimulated macrophage cells

Toxicology Letters

Volumn 202, Issue 2, 2011, Pages 93-99

  Liu, Ming Chao ^a   Lin, Ting Hui ^a   Wu, Ting Shuan ^a   Yu, Feng Yih ^a   Lu, Chuan Chen ^a   Liu, Biing Hui ^b  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Aristolochic acid I; INOS; LPS; Macrophage; NF B

Indexed keywords

ARISTOLOCHIC ACID; ARISTOLOCHIC ACID 1; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; LUCIFERASE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; BINDING SITE; CELL FUNCTION; DNA BINDING; ENZYME ACTIVITY; ENZYME STABILITY; GENE DELETION; GENE EXPRESSION; MACROPHAGE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION;

ANIMALS; ARISTOLOCHIC ACIDS; BLOTTING, WESTERN; CELL LINE; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MACROPHAGES; MICE; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79952628187     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2011.01.021     Document Type: Article

References (44)

1. Aktan F. iNOS-mediated nitric oxide production and its regulation. Life Sci. 2004, 75:639-653.
2. Arlt V.M., Zuo J., Trenz K., Roufosse C.A., Lord G.M., Nortier J.L., Schmeiser H.H., Hollstein M., Phillips D.H. Gene expression changes induced by the human carcinogen aristolochic acid I in renal and hepatic tissue of mice. Int. J. Cancer 2010, 10.1002/ijc.25324.
3. Baeuerle P.A., Baltimore D. NF-kappa B: ten years after. Cell 1996, 87:13-20.
4. Bogdan C., Rollinghoff M., Diefenbach A. The role of nitric oxide in innate immunity. Immunol. Rev. 2000, 173:17-26.
5. Boshart M., Weber F., Jahn G., Dorsch-Hasler K., Fleckenstein B., Schaffner W. A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 1985, 41:521-530.
6. Burdelya L., Kujawski M., Niu G., Zhong B., Wang T., Zhang S., Kortylewski M., Shain K., Kay H., Djeu J., Dalton W., Pardoll D., Wei S., Yu H. Stat3 activity in melanoma cells affects migration of immune effector cells and nitric oxide-mediated antitumor effects. J. Immunol. 2005, 174:3925-3931.
7. Chen T., Guo L., Zhang L., Shi L., Fang H., Sun Y., Fuscoe J.C., Mei N. Gene expression profiles distinguish the carcinogenic effects of aristolochic acid in target (kidney) and non-target (liver) tissues in rats. BMC Bioinformatics 7 Suppl. 2006, 2:S20.
8. Chen Y.Y., Chiang S.Y., Wu H.C., Kao S.T., Hsiang C.Y., Ho T.Y., Lin J.G. Microarray analysis reveals the inhibition of nuclear factor-kappa B signaling by aristolochic acid in normal human kidney (HK-2) cells. Acta Pharmacol. Sinica 2010, 31:227-236.
9. Collart M.A., Baeuerle P., Vassalli P. Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B. Mol. Cell. Biol. 1990, 10:1498-1506.
10. Connelly L., Palacios-Callender M., Ameixa C., Moncada S., Hobbs A.J. Biphasic regulation of NF-kappa B activity underlies the pro- and anti-inflammatory actions of nitric oxide. J. Immunol. 2001, 166:3873-3881.
11. Ganster R.W., Taylor B.S., Shao L., Geller D.A. Complex regulation of human inducible nitric oxide synthase gene transcription by Stat 1 and NF-kappa B. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:8638-8643.
12. Ghosh S., Hayden M.S. New regulators of NF-kappaB in inflammation. Nat. Rev. 2008, 8:837-848.
13. Gold L.S., Slone T.H. Aristolochic acid, an herbal carcinogen, sold on the Web after FDA alert. N. Engl. J. Med. 2003, 349:1576-1577.
14. Habara K., Hamada Y., Yamada M., Tokuhara K., Tanaka H., Kaibori M., Kamiyama Y., Nishizawa M., Ito S., Okumura T. Pitavastatin up-regulates the induction of iNOS through enhanced stabilization of its mRNA in pro-inflammatory cytokine-stimulated hepatocytes. Nitric Oxide 2008, 18:19-27.
15. Huang C.C., Chen P.C., Huang C.W., Yu J. Aristolochic acid induces heart failure in zebrafish embryos that is mediated by inflammation. Toxicol. Sci. 2007, 100:486-494.
16. IARC Summaries and Evaluation Aristolochia Species and Aristolochic Acids, vol. 82 2002, International Agency for Research on Caner, Lyon, France, pp. 69-71.
17. Jacobs A.T., Ignarro L.J. Lipopolysaccharide-induced expression of interferon-beta mediates the timing of inducible nitric-oxide synthase induction in RAW 264.7 macrophages. J. Biol. Chem. 2001, 276:47950-47957.
18. Juang S.H., Xie K., Xu L., Shi Q., Wang Y., Yoneda J., Fidler I.J. Suppression of tumorigenicity and metastasis of human renal carcinoma cells by infection with retroviral vectors harboring the murine inducible nitric oxide synthase gene. Hum. Gene Ther. 1998, 9:845-854.
19. Karin M., Cao Y., Greten F.R., Li Z.W. NF-κB in cancer: from innocent bystander to major culprit. Nat. Rev. 2002, 2:301-310.
20. Lee T.Y., Wu M.L., Deng J.F., Hwang D.F. High-performance liquid chromatographic determination for aristolochic acid in medicinal plants and slimming products. J. Chromagr. B 2001, 766:169-174.
21. Li W., Gong S., Wen D., Che B., Liao Y., Liu H., Feng X., Hu S. Rapid determination of aristolochic acid I and II in Aristolochia plants from different regions by beta-cyclodextrin-modified capillary zone electrophoresis. J. Chromatogr. A 2004, 1049:211-217.
22. Liu B.H., Wu T.S., Yu F.Y., Wang C.H. Mycotoxin patulin activates the p38 kinase and JNK signaling pathways in human embryonic kidney cells. Toxicol. Sci. 2006, 89:423-430.
23. Liu Q., Wang Q., Yang X., Shen X., Zhang B. Differential cytotoxic effects of denitroaristolochic acid II and aristolochic acids on renal epithelial cells. Toxicol. Lett. 2009, 184:5-12.
24. Lord G.M., Cook T., Arlt V.M., Schmeiser H.H., Williams G., Pusey C.D. Urothelial malignant disease and Chinese herbal nephropathy. Lancet 2001, 358:1515-1516.
25. Lowenstein C.J., Alley E.W., Raval P., Snowman A.M., Snyder S.H., Russell S.W., Murphy W.J. Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:9730-9734.
26. Matsui K., Nishizawa M., Ozaki T., Kimura T., Hashimoto I., Yamada M., Kaibori M., Kamiyama Y., Ito S., Okumura T. Natural antisense transcript stabilizes inducible nitric oxide synthase messenger RNA in rat hepatocytes. Hepatol. Baltimore Md. 2008, 47:686-697.
27. Moreno J.J. Effect of aristolochic acid on arachidonic acid cascade and in vivo models of inflammation. Immunopharmacology 1993, 26:1-9.
28. Pozdzik A.A., Salmon I.J., Husson C.P., Decaestecker C., Rogier E., Bourgeade M.F., Deschodt-Lanckman M.M., Vanherweghem J.L., Nortier J.L. Patterns of interstitial inflammation during the evolution of renal injury in experimental aristolochic acid nephropathy. Nephrol. Dial. Transplant. 2008, 23:2480-2491.
29. Rodriguez-Pascual F., Hausding M., Ihrig-Biedert I., Furneaux H., Levy A.P., Forstermann U., Kleinert H. Complex contribution of the 3'-untranslated region to the expressional regulation of the human inducible nitric-oxide synthase gene. Involvement of the RNA-binding protein HuR. J. Biol. Chem. 2000, 275:26040-26049.
30. Rosenthal M.D., Vishwanath B.S., Franson R.C. Effects of aristolochic acid on phospholipase A2 activity and arachidonate metabolism of human neutrophils. Biochim. Biophys. Acta 1989, 1001:1-8.
31. Schneemann M., Schoeden G. Macrophage biology and immunology: man is not a mouse. J. Leuk. Biol. 2007, 81:579.
32. Shibutani S., Dong H., Suzuki N., Ueda S., Miller F., Grollman A.P. The Selective toxicity of aristolochic acids I and II. Drug Metab. Dispos. 2007, 35:1217-1222.
33. Shimomura-Shimizu M., Sugiyama K., Muroi M., Tanamoto K. Alachlor and carbaryl suppress lipopolysaccharide-induced iNOS expression by differentially inhibiting NF-kappaB activation. Biochem. Biophys. Res. Commun. 2005, 332:793-799.
34. Soderberg M., Raffalli-Mathieu F., Lang M.A. Identification of a regulatory cis-element within the 3'-untranslated region of the murine inducible nitric oxide synthase (iNOS) mRNA; interaction with heterogeneous nuclear ribonucleoproteins I and L and role in the iNOS gene expression. Mol. Immunol. 2007, 44:434-442.
35. Spink J., Evans T. Binding of the transcription factor interferon regulatory factor-1 to the inducible nitric-oxide synthase promoter. J. Biol. Chem. 1997, 272:24417-24425.
36. Sugiyama K., Muroi M., Tanamoto K., Nishijima M., Sugita-Konishi Y. Deoxynivalenol and nivalenol inhibit lipopolysaccharide-induced nitric oxide production by mouse macrophage cells. Toxicol. Lett. 2010, 192:150-154.
37. Vanherweghem J.L., Depierreux M., Tielemans C., Abramowicz D., Dratwa M., Jadoul M., Richard C., Vandervelde D., Verbeelen D., Vanhaelen-Fastre R. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet 1993, 341:387-391.
38. Verdon C.P., Burton B.A., Prior R.L. Sample pretreatment with nitrate reductase and glucose-6-phosphate dehydrogenase quantitatively reduces nitrate while avoiding interference by NADP+ when the Griess reaction is used to assay for nitrite. Anal. Biochem. 1995, 224:502-508.
39. Wong C.P., Bray T.M., Ho E. Induction of proinflammatory response in prostate cancer epithelial cells by activated macrophages. Cancer Lett. 2009, 276:38-46.
40. Xie K., Dong Z., Fidler I.J. Activation of nitric oxide synthase gene for inhibition of cancer metastasis. J. Leuk. Biol. 1996, 59:797-803.
41. Xie Q.W., Kashiwabara Y., Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J. Biol. Chem. 1994, 269:4705-4708.
42. Xie Q.W., Whisnant R., Nathan C. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide. J Exp Med. 1993, 177:1779-1784.
43. Yoshida H., Kwon A.H., Kaibori M., Tsuji K., Habara K., Yamada M., Kamiyama Y., Nishizawa M., Ito S., Okumura T. Edaravone prevents iNOS expression by inhibiting its promoter transactivation and mRNA stability in cytokine-stimulated hepatocytes. Nitric Oxide 2008, 18:105-112.
44. Yu F.Y., Lin Y.H., Su C.C. A sensitive enzyme-linked immunosorbent assay for detecting carcinogenic aristolochic acid in herbal remedies. J. Agric. Food Chem. 2006, 54:2496-2501.